Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Clinical trial NCT04439006 · COMPLETED

Trial details

NCT number: NCT04439006
Sponsor: Jennifer Woyach
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Aplastic Anemia Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Monoclonal B-Cell Lymphocytosis Monoclonal Gammopathy of Undetermined Significance Myelodysplastic Syndrome Symptomatic COVID-19 Infection Laboratory-Confirmed

Start date: 2020-10-23
Primary completion: 2022-09-20
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.